Confined Acids Catalyze a Broadly Applicable β-Selective O-Glycosylation
Jiaxiang Lu1, Tianyu Zheng1, Satoshi Matsutani2
1Max-Planck-Institut für Kohlenforschung, 45470 Mülheim an der Ruhr, Germany.
Journal of the American Chemical Society
|April 6, 2026
Summary
Chemists developed a new method for creating specific sugar linkages in glycans, overcoming previous selectivity challenges. This breakthrough uses confined acids for precise beta-selective O-glycosylation, advancing carbohydrate chemistry.
Area of Science:
- Carbohydrate Chemistry
- Organic Synthesis
- Glycoscience
Background:
- Glycans are crucial biological molecules, with glycosidic bond stereochemistry dictating structure and function.
- Stereocontrolled synthesis of glycosidic linkages is a significant challenge in chemistry.
- Existing catalytic beta-selective glycosylations often suffer from poor selectivity due to competing reaction pathways.
Purpose of the Study:
- To develop a novel catalytic method for broadly applicable and highly stereoselective beta-O-glycosylation.
- To investigate an alternative reaction pathway distinct from traditional SN2-like glycosylations.
- To enable precise synthesis of complex glycans, including challenging 2-deoxy sugars.
Main Methods:
- Utilized confined acids as catalysts for O-glycosylation reactions.
- Performed a range of beta-selective glycosylations, including glucosylation and mannosylation.
- Conducted mechanistic studies and theoretical calculations to elucidate the reaction pathway.
Main Results:
- Demonstrated a broadly applicable catalytic beta-selective O-glycosylation method.
- Achieved high selectivity in glycosylations, including challenging substrates like 2-deoxyglucosylation.
- Identified a proposed SN1-like pathway facilitated by confined acid catalysis, distinct from prior methods.
Conclusions:
- Confined acid catalysis provides a novel and effective strategy for stereocontrolled beta-O-glycosylation.
- This approach overcomes limitations of previous methods, offering improved selectivity and broader applicability.
- The findings advance the synthesis of complex carbohydrates and glycoconjugates.
Related Concept Videos
Oligosaccharide Assembly
3.9K
Protein glycosylation starts in the ER lumen and continues in the Golgi apparatus. Glycosyltransferases catalyze the addition of sugar molecules or glycosylation of proteins. Usually, these enzymes add sugars to the hydroxyl groups of selected serine or threonine residues to form O-linked glycans or the amino groups of asparagine residues to form N-linked glycans. Different positions on the same polypeptide chain can contain differently linked glycans.
Multiple sugar molecules that may or may...
Multiple sugar molecules that may or may...
3.9K
Proteoglycans
5.2K
Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
5.2K
Protein Glycosylation
10.5K
Glycosylation, the most common post-translational modification for proteins, serves diverse functions. Adding sugars to proteins makes the proteins more resistant to proteolytic digestion. Glycosylated proteins can act as markers and receptors to promote cell-cell adhesion. Additionally, they have many essential quality control functions in the cell, such as correct protein folding and facilitating transport of misfolded proteins to the cytosol, which can be degraded.
Glycosylation occurs in...
Glycosylation occurs in...
10.5K
Protein Folding Quality Check in the RER
5.7K
ER is the primary site for the maturation and folding of soluble and transmembrane secretory proteins. The calnexin cycle is a specific chaperone system that folds and assesses the confirmation of N-glycosylated proteins before they can exit the ER lumen. The primary players of this quality check pipeline are the lectins, ER-resident chaperones, and a glucosyl transferase enzyme. In case the calnexin system in the lumen fails to salvage a misfolded protein, it is transported to the cytoplasm...
5.7K
Transducer Mechanism: Enzyme-Linked Receptors
4.9K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
4.9K
Protein Modifications in the RER
7.6K
Modification of secretory and transmembrane proteins entering the rough ER begins in the ER lumen. These modifications aid in protein folding and stabilize the acquired tertiary structure. Protein modifications in the rough ER co-occur at different stages of protein folding.
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal...
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal...
7.6K


